Following the posts from @kdwc on the Research thread, what today's contract announcement reiterates is that there is now double the chance of material announcements of this sort (4DX and Imbio in their own right) that could lead to material positive moves in SP.
It is also a calendar year where Imbio is expected to secure further FDA and/or EMA approvals.
Following the posts from @kdwc on the Research thread, what...
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
55.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $217.2M | |||
| Open | High | Low | Value | Volume |
| 57.0¢ | 60.0¢ | 55.5¢ | $1.001M | 1.749M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 37705 | 55.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 56.5¢ | 4050 | 1 |
View Market Depth
| Last trade - 16.10pm 09/05/2024 (20 minute delay) ? |
|
|||||
|
Last
56.0¢ |
Change
0.000 ( 0.83 %) |
||||
| Open | High | Low | Volume | ||
| 56.0¢ | 59.3¢ | 55.5¢ | 275215 | ||
| Last updated 15.59pm 09/05/2024 ? | |||||
| 4DX (ASX) Chart |